Hitgen, Inc. is a biotechnology company based in Sichuan, China, specializing in the development of innovative drug discovery technologies. The company focuses on leveraging its proprietary platform for generating and optimizing peptide and small molecule libraries, facilitating the identification of novel therapeutic candidates. Hitgen's research efforts are primarily directed towards addressing unmet medical needs across various therapeutic areas, including oncology and infectious diseases, positioning it as a key player in the biopharmaceutical landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

10 Patents

#17 in

#2,795 in

#55,986 in the World

Sichuan, China

Hitgen, Inc.

Forward Citations = 2

43 inventors:

Jin Li (8 out of 8 patents)

Dengyou Zhang (4 out of 4 patents)

Jinqiao Wan (4 out of 4 patents)

4. Dengfeng Dou (4 out of 4 patents)

5. Yan Lan (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Hitgen, Inc.. Retrieved from https://idiyas.com/company/hitgen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

10 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]